Making administrative healthcare systems clinical data the future of clinical trials: lessons from BladderPath.
作者信息
Mintz Harriet Paige, Dosanjh Amandeep Raj Singh, Parsons Helen, Sydes Matthew, Bryan Richard T, James Nicholas D, Patel Prashant
机构信息
University of Birmingham Medical School, University of Birmingham, Birmingham, UK.
MRC Clinical Trials Unit, University College London, London, UK.
出版信息
BMJ Oncol. 2023 Jul 17;2(1):e000038. doi: 10.1136/bmjonc-2023-000038. eCollection 2023.
Abstract
摘要
相似文献
1
Making administrative healthcare systems clinical data the future of clinical trials: lessons from BladderPath.将医疗保健管理系统的临床数据打造成临床试验的未来：来自BladderPath的经验教训。
BMJ Oncol. 2023 Jul 17;2(1):e000038. doi: 10.1136/bmjonc-2023-000038. eCollection 2023.
2
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial.利用常规临床数据作为传统设计的替代方案，进行一项随机对照试验随访方法的开发与验证：一项评估用于膀胱路径试验可行性的试点研究。
Pilot Feasibility Stud. 2020 Oct 31;6(1):165. doi: 10.1186/s40814-020-00713-y.
3
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.影像指导膀胱癌治疗路径再设计：膀胱癌路径 RCT。
Health Technol Assess. 2024 Aug;28(42):1-65. doi: 10.3310/DEHT5407.
4
Improving the pathway to correct treatment for patients with muscle-invasive bladder cancer: exploring the myths around the BladderPath trial.改善肌层浸润性膀胱癌患者的正确治疗途径：探寻围绕BladderPath试验的误解
BJU Int. 2025 Jul;136(1):34-37. doi: 10.1111/bju.16728. Epub 2025 Apr 14.
5
Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.比较影像引导路径与标准路径用于分期肌层浸润性膀胱癌：来自 BladderPath 研究的初步数据。
Eur Urol. 2021 Jul;80(1):12-15. doi: 10.1016/j.eururo.2021.02.021. Epub 2021 Feb 27.
6
Lessons Learned: It Takes a Village to Understand Inter-Sectoral Care Using Administrative Data across Jurisdictions.经验教训：跨辖区利用行政数据理解跨部门医疗服务需要各方协作。
Int J Popul Data Sci. 2018 Nov 12;3(3):440. doi: 10.23889/ijpds.v3i3.440.
7
Re: Richard T. Bryan, Wenyu Liu, Sarah J. Pirrie, et al. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study. Eur Urol 2021;80:12-5.回复：理查德·T·布莱恩、刘文宇、莎拉·J·皮里等人。比较影像引导途径与标准途径对肌层浸润性膀胱癌进行分期：来自膀胱路径研究的初步数据。《欧洲泌尿外科杂志》2021年；80卷：12 - 5页。
Eur Urol. 2021 Sep;80(3):e85. doi: 10.1016/j.eururo.2021.06.018. Epub 2021 Jun 30.
8
Erratum: Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.勘误：磁共振成像与经尿道切除术用于新发性膀胱癌分期的随机对照比较：前瞻性膀胱路径试验结果
J Clin Oncol. 2025 May 20;43(15):1847. doi: 10.1200/JCO-25-00779. Epub 2025 Apr 23.
9
Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom.从大规模数据库中汲取的早期前列腺癌经验教训：基于人群的智慧结晶。
Surg Oncol. 2002 Jun;11(1-2):3-11. doi: 10.1016/s0960-7404(02)00009-9.
10
Lessons learned from conducting the first cancer care delivery trial in the Alliance for Clinical Trials in Oncology (Alliance A191402CD).从肿瘤临床联盟（Alliance A191402CD）进行的首个癌症护理临床试验中汲取的经验教训。
Clin Trials. 2023 Oct;20(5):559-563. doi: 10.1177/17407745231167123. Epub 2023 Apr 12.
本文引用的文献
1
Data provenance and integrity of health-care systems data for clinical trials.临床试验医疗保健系统数据的数据来源与完整性。
Lancet Digit Health. 2022 Aug;4(8):e567-e568. doi: 10.1016/S2589-7500(22)00122-4.
2
Realising the full potential of data-enabled trials in the UK: a call for action.挖掘英国数据驱动型试验的全部潜力：行动呼吁。
BMJ Open. 2021 Jun 16;11(6):e043906. doi: 10.1136/bmjopen-2020-043906.
3
Accessing routinely collected health data to improve clinical trials: recent experience of access.获取常规健康数据以改善临床试验：近期获取经验。
Trials. 2021 May 10;22(1):340. doi: 10.1186/s13063-021-05295-5.
4
Data, data all around.数据，到处都是数据。
Lancet Digit Health. 2021 Apr 8;3(5):e284-5. doi: 10.1016/S2589-7500(21)00063-7.
5
Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.比较影像引导路径与标准路径用于分期肌层浸润性膀胱癌：来自 BladderPath 研究的初步数据。
Eur Urol. 2021 Jul;80(1):12-15. doi: 10.1016/j.eururo.2021.02.021. Epub 2021 Feb 27.
6
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial.利用常规临床数据作为传统设计的替代方案，进行一项随机对照试验随访方法的开发与验证：一项评估用于膀胱路径试验可行性的试点研究。
Pilot Feasibility Stud. 2020 Oct 31;6(1):165. doi: 10.1186/s40814-020-00713-y.
7
Access to routinely collected health data for clinical trials - review of successful data requests to UK registries.获取常规收集的临床试验健康数据 - 对英国注册机构成功的数据请求进行审查。
Trials. 2020 May 12;21(1):398. doi: 10.1186/s13063-020-04329-8.
8
Routinely collected data for randomized trials: promises, barriers, and implications.随机试验的常规收集数据：前景、障碍及影响
Trials. 2018 Jan 11;19(1):29. doi: 10.1186/s13063-017-2394-5.
9
The prevention and treatment of missing data in clinical trials.临床试验中缺失数据的预防与处理
N Engl J Med. 2012 Oct 4;367(14):1355-60. doi: 10.1056/NEJMsr1203730.
Zotero 插件